Up-regulated BCAR4 contributes to proliferation and migration of cervical cancer cells

被引：38
|
作者：
Zou, Ruanmin [1 ]
Chen, Xiangjian [2 ]
Jin, Xuejing [3 ]
Li, Shi [4 ]
Ou, Rongying [1 ]
Xue, Jisen [1 ]
Yan, Xiaojian [1 ]
Chen, Lulu [1 ]
Hu, Yan [1 ]
Zhu, Hua [1 ]
机构：
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Wenzhou 325000, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Wenzhou, Peoples R China
[3] Hangzhou Matern & Child Hlth Care Hosp, Hangzhou Womens Hosp, Hangzhou, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 1, Dept Urol, Wenzhou, Peoples R China
来源：
SURGICAL ONCOLOGY-OXFORD | 2018年 / 27卷 / 02期
关键词：
LncRNA; BCAR4; Cervical cancer; NONCODING RNA BCAR4; POOR-PROGNOSIS; PROMOTES PROLIFERATION; INVASION; METASTASIS; OSTEOSARCOMA; EXPRESSION;
D O I：
10.1016/j.suronc.2018.05.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OBJECTIVES: Recently, thousands of long non-coding RNAs (lncRNAs) involved in development and metastasis of malignant tumors have been identified. Long non-coding RNA (IncRNA) breast cancer antiestrogen resistance 4 (BCAR4) has been proved to promote proliferation and metastasis in multiple tumors. However, the function and significance of BCAR4 in cervical cancer are still unclear. METHODS: In this study, we concentrated on the biological function and clinical significance of BCAR4 in cervical cancer. More specifically, BCAR4 expression was evaluated in cervical cancer tissues and cell lines by qRT-PCR. Moreover, the prognostic factors were assessed by Kaplan-Meier analysis and Cox proportional hazards models. Additionally, functional assays were conducted and the potential mechanism was explored. RESULTS: Our study showed that BCAR4 expression was significantly up-regulated in cervical cancer tissue and cell lines. Moreover, patients with high BCAR4 expression showed worse survival outcomes and overexpression of BCAR4 might be an independent prognostic factor in cervical cancer. Furthermore, overexpression of BCAR4 remarkably promoted the proliferation, motility of cervical cancer cells and silencing BCAR4 significantly suppressed the proliferation, migration and invasion of cervical cancer cells. Additionally, overexpression of BCAR4 promoted epithelial-mesenchymal transition (EMT) process and silencing BCAR4 suppressed EMT process in cervical cancer cells. CONCLUSIONS: The results indicated that BCAR4 might play a crucial role in cervical cancer progression and act as an underlying biomarker for the diagnosis and prognosis of cervical cancer. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码：306 / 313
页数：8
相关论文
共 50 条
  • [31] Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer
    Godinho, M. F. E.
    Sieuwerts, A. M.
    Look, M. P.
    Meijer, D.
    Foekens, J. A.
    Dorssers, L. C. J.
    van Agthoven, T.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 103 (08) : 1284 - 1291
  • [32] Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer
    M F E Godinho
    A M Sieuwerts
    M P Look
    D Meijer
    J A Foekens
    L C J Dorssers
    T van Agthoven
    [J]. British Journal of Cancer, 2010, 103 : 1284 - 1291
  • [33] BCAR4 Expression as a Predictive Biomarker for Endocrine Therapy Resistance in Breast Cancer
    Liao, Muheng
    Webster, Jace
    Coonrod, Emily M.
    Weilbaecher, Katherine N.
    Maher, Christopher A.
    White, Nicole M.
    [J]. CLINICAL BREAST CANCER, 2024, 24 (04)
  • [34] UP-REGULATED CIRCPOLD1 PROMOTES TUMORIGENESIS IN CERVICAL CANCER
    Zhao, L.
    Zhang, Y.
    Lv, W.
    Cheng, X.
    Xie, X.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A83 - A84
  • [35] ERH is up-regulated in bladder cancer and regulates the proliferation and apoptosis of T24 bladder cancer cells
    Pang, Kun
    Lv, Qian
    Ning, Songyi
    Hao, Lin
    Shi, Zhenduo
    Zang, Guanghui
    Shen, Ke
    Zhu, Xiangying
    Zhu, Guangyuan
    Wang, Xuan
    Han, Conghui
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (11): : 15269 - 15277
  • [36] LncRNA BCAR4 promotes proliferation, invasion and metastasis of non-small cell lung cancer cells by affecting epithelial-mesenchymal transition
    Li, N.
    Gao, W. -J.
    Liu, N. -S.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (09) : 2075 - 2086
  • [37] Long non-coding RNA BCAR4 promotes chondrosarcoma cell proliferation and migration through activation of mTOR signaling pathway
    Shui, Xiaolong
    Zhou, Chengwei
    Lin, Wei
    Yu, Yang
    Feng, Yongzeng
    Kong, Jianzhong
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2017, 242 (10) : 1044 - 1050
  • [38] Identification of signaling pathways activated by BCAR4 expression in human breast cancer
    Godinho, Marcia F. E.
    Wulfkuhle, Julia D.
    Petricoin, Emanuel F.
    Dorssers, Lambert C. J.
    van Agthoven, Ton
    [J]. CANCER RESEARCH, 2011, 71
  • [39] Breast cancer anti-estrogen resistance 4 (BCAR4) is a novel oncogene in lung cancer
    Bae, Kieun
    Lee, Minkyong
    Yoon, Daseul
    Kim, Yun-Hee
    Yoon, Kyong-Ah
    [J]. CANCER RESEARCH, 2017, 77
  • [40] FOXC2 is up-regulated in pancreatic ductal adenocarcinoma and promotes the growth and migration of cancer cells
    Cui, Lei
    Dang, Shengchun
    Qu, Jianguo
    Mao, Zhengfa
    Wang, Xuqing
    Zhang, Jianxin
    Chen, Jixiang
    [J]. TUMOR BIOLOGY, 2016, 37 (07) : 8579 - 8585
12345